His primary scientific interests are in Pathology, Glioma, Cancer research, Meningioma and Astrocytoma. His Pathology research integrates issues from Fluorescence in situ hybridization, Monosomy and Gene expression profiling. His Glioma study deals with Internal medicine intersecting with Selumetinib and Gastroenterology.
His study in Cancer research is interdisciplinary in nature, drawing from both Tumor suppressor gene, Oncogene and Mutation. His study in the field of Benign Meningioma also crosses realms of Mitotic index. His Astrocytoma research includes themes of ATRX and Ganglioglioma.
His primary areas of investigation include Pathology, Meningioma, Glioma, Immunohistochemistry and Cancer research. Arie Perry works in the field of Pathology, namely Neurofibromatosis. His work deals with themes such as Merlin and Oncology, which intersect with Meningioma.
The various areas that Arie Perry examines in his Glioma study include Brain tumor and Internal medicine. His Immunohistochemistry study frequently draws connections between adjacent fields such as Differential diagnosis. His Cancer research research incorporates themes from Mutation and Tumor suppressor gene.
Arie Perry focuses on Pathology, Meningioma, Internal medicine, Oncology and Cancer research. His Pathology research is multidisciplinary, incorporating elements of Astrocytoma, Glioma and Magnetic resonance imaging. His Meningioma study combines topics from a wide range of disciplines, such as Transcriptome, Local failure and Proportional hazards model.
As part of one scientific family, Arie Perry deals mainly with the area of Oncology, narrowing it down to issues related to the ATRX, and often CDKN2A. His Cancer research study incorporates themes from Mutation, Missense mutation and Epigenetics. Arie Perry has researched Mutation in several fields, including DNA methylation and Exon.
Arie Perry spends much of his time researching Pathology, Meningioma, Internal medicine, Glioma and Oncology. Arie Perry connects Pathology with Extramural in his research. Arie Perry interconnects Local failure, Resection, Recursive partitioning and Nomogram in the investigation of issues within Meningioma.
The Internal medicine study combines topics in areas such as Gastroenterology, Anaplastic astrocytoma and Selumetinib. His Glioma research incorporates elements of Not Otherwise Specified, IDH1 R132H and Psychoanalysis. His Oncology research is multidisciplinary, incorporating perspectives in Diffuse Astrocytoma, Clinical trial, Retrospective cohort study and ATRX.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N. Louis;Arie Perry;Guido Reifenberger;Andreas von Deimling.
Acta Neuropathologica (2016)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh.
The New England Journal of Medicine (2015)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
Justin S. Smith;Arie Perry;Thomas J. Borell;Hyun K. Lee.
Journal of Clinical Oncology (2000)
DNA methylation-based classification of central nervous system tumours
David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Meningioma grading: an analysis of histologic parameters.
Arie Perry;Scott L. Stafford;Bernd W. Scheithauer;Vera J. Suman.
The American Journal of Surgical Pathology (1997)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis;Arie Perry;Peter Burger;David W. Ellison.
Brain Pathology (2014)
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool;David T.W. Jones;Natalie Jäger;Paul A. Northcott.
Cancer Cell (2014)
Notch1 and notch2 have opposite effects on embryonal brain tumor growth.
Xing Fan;Irina Mikolaenko;Ihab Elhassan;Xing Zhi Ni.
Cancer Research (2004)
Histological classification and molecular genetics of meningiomas
Markus J Riemenschneider;Arie Perry;Guido Reifenberger.
Lancet Neurology (2006)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison;James Dalton;Mehmet Kocak;Sarah Leigh Nicholson.
Acta Neuropathologica (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: